9th Annual Swedish-American Life Science Summit (SALSS) to Focus on Global Aging and Enhanced Health From August 21st to 23rd

9th Annual Swedish-American Life Science Summit (SALSS) to Focus on Global 
Aging and Enhanced Health From August 21st to 23rd in
Stockholm 
Regenerative Medicine, Stem Cells, Entrepreneurship and Opportunities
on the Brazilian Market Will Be Featured 
STOCKHOLM, SWEDEN -- (Marketwired) -- 08/20/13 --  The
Swedish-American Life Science Summit (SALSS) today announced that
this year's conference will focus on Global Aging and opportunities
for Enhanced Health utilizing Regenerative Medicine, including Stem
Cells. 
With the mission to nurture exciting new sciences into successful
ventures SALSS combines the worlds' of Business and Life Science for
cutting edge discussions and exclusive networking opportunities.
"Over the years SALSS has evolved to a highly recognized summit
bringing together international decision makers discussing the
forefronts of technology and business. Last year, the Institutional
Investor concluded after the SALSS conference that Stockholm has now
become the deal making hub for Life Science, which makes us very
proud," says Barbro C. Ehnbom, Founder and Chairman of SALSS. 
By exploring new technologies, such as regenerative medicine and the
ever expanding use of stem cell research, this year's topics will not
only cover ways to enhance our healthspan but also to decrease
healthcare delivery costs globally. 
"I am convinced that the key to accelerating medical research and
improving global healthspan is to break down silos. Accelerating
innovation means getting academicians, investors, business people and
regulatory people in the same room, where they can share ideas and
create novel strategies. SALSS can have a major impact driving these
changes," says Dr. Brian K Kennedy, CEO, the Buck Institute for Aging
Research.  
Amongst an impressive presence of private equity groups, investors,
life science companies and academia, this year's program features Dr.
Kennedy, cited above, as well as Susan Solomon, Co-Founder of the New
York Stem Cell Foundation, Dr. Jan Lundberg, President, Lilly
Research Laboratories and Jamie Oliveira, Director, ANVISA, the
Medical Products Agency of Brazil. The segment on Entrepreneurship
will start off with a unique opportunity to hear Dr. Hakan
Bjoerklund, Chairman of Lundbeck, talk about the incredible success
story of Nycomed, sold to Takeda Pharmaceutical for EUR 9.6 billion
in 2011. 
ABOUT SALSS 2013 The Swedish-American Life Science Summit 2013 is the
ninth annual summit, an invitation-only format where the program
features some of the best known Life Science executives and investors
in the world. The objective is to stimulate the Life Science sector
in Sweden, paving the way for new investments and establish Stockholm
as an international leading innovation and research center. The
intense three-day program includes panel discussions and
presentations of selected, successful and promising companies. Barbro
C. Ehnbom, Founder and Chairman of SALSS, has been a pioneer in the
Life Science industry throughout her whole career.  
For more information on SALSS, visit www.salss.com  
Barbro C. Ehnbom 
Chairman 
E-mail: be@swedishamericanlifescience.com 
Tel: +46 8 736 9334 / 35 
 
 
Press spacebar to pause and continue. Press esc to stop.